Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock
Status:
RECRUITING
Trial end date:
2026-06-20
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to investigate whether methylene blue injection can safely and effectively improve the survival rate of patients with severe septic shock, shorten the duration of norepinephrine use, reduce the dosage of vasopressors, promptly correct hemodynamics, and improve tissue perfusion and organ function impairment.
Phase:
NA
Details
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Collaborators:
Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University GUI LIN PEOPLE'S HOSPITAL Hangzhou Yuhang District Second People's Hospital NINGBO MEDICAL CENTER LIHUIIHOSPITAI People's Hospital of Guangxi Zhuang Autonomous Region Taizhou Enze Medical Center Group The First People's Hospital of Huzhou The second Nanning People's Hospital Wuming Hospital of Guangxi Medical University Yuyao People's Hospital